David A. Siegel Care Dx, Inc. Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Care Dx, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 187,700 shares of CDNA stock, worth $2.91 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
187,700
Previous 228,900
18.0%
Holding current value
$2.91 Million
Previous $2.75 Million
27.64%
% of portfolio
0.0%
Previous 0.01%
Shares
26 transactions
Others Institutions Holding CDNA
# of Institutions
150Shares Held
55.1MCall Options Held
85.8KPut Options Held
48.8K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.86MShares$91.1 Million0.44% of portfolio
-
Black Rock Inc. New York, NY5.43MShares$84.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.3MShares$66.8 Million0.0% of portfolio
-
State Street Corp Boston, MA4.2MShares$65.2 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.93MShares$61.1 Million0.65% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $830M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...